Health Management (HMA) Shares Rebound as Susquehanna Defends, Says Buy the Dip
Tweet Send to a FriendGet Alerts HMA Hot Sheet
Price: $15.53 -4.84%
Rating Summary:
12 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Rating Summary:
12 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Trade HMA Now!
Shares of Health Management Associates (NYSE: HMA) have bounced by more than 4 percent over the last hour of trade as Susquehanna's AJ Rice issued a mid-day note suggesting clients buy into Monday morning's weakness.
After trading to as low as $6.55 earlier, the stock is now down 8.5 percent to $6.85.
Shares were down more than 12 percent earlier on the heels of a CRT Capital report which considered a lawsuit from an ex-auditor who also happened to be an ex-FBI agent.
Susquehanna's Rice maintains a Positive rating and $11 price target on shares of Health Management Associates.
Visit our Analyst Ratings page to track all the market-moving analyst calls on shares of Health Management.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
After trading to as low as $6.55 earlier, the stock is now down 8.5 percent to $6.85.
Shares were down more than 12 percent earlier on the heels of a CRT Capital report which considered a lawsuit from an ex-auditor who also happened to be an ex-FBI agent.
Susquehanna's Rice maintains a Positive rating and $11 price target on shares of Health Management Associates.
Visit our Analyst Ratings page to track all the market-moving analyst calls on shares of Health Management.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Mizuho Securities Downgrades Health Management (HMA) to Neutral
- Switching From Apple (AAPL) iPhone to Samsung Galaxy S4 Costs $78.85 and Headache
- UPDATE: Viropharma, Inc. (VPHM) Said to Attract Acquisition Interest - Reuters
Create E-mail Alert Related Categories
Analyst Comments, Momentum MoversRelated Entities
Susquehanna International Group of CompaniesLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

